Citations to this article

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
A Daugherty, … , S E Roselaar, D J Rader
A Daugherty, … , S E Roselaar, D J Rader
Published September 15, 1997
Citation Information: J Clin Invest. 1997;100(6):1575-1580. https://doi.org/10.1172/JCI119681.
View: Text | PDF
Research Article

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.

Abstract

Research Article

Authors

A Daugherty, E Puré, D Delfel-Butteiger, S Chen, J Leferovich, S E Roselaar, D J Rader

×

Total citations by year

Year: 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 2 3 4 3 4 6 13 5 5 8 4 12 6 6 7 8 7 9 11 18 14 16 18 8 197
Citation information

Citations to this article in year 2003 (11)

Title and authors Publication Year
Disruption of TGF-beta signalling in T cells accelerates atherosclerosis
Anna-Karin L Robertson, Mats Rudling, Xinghua Zhou, Leonid Gorelik, Richard A Flavell and Göran K Hansson 		Journal of Clinical Investigation 2003
HIV Protease Inhibitors Promote Atherosclerotic Lesion Formation Independent of Dyslipidemia by Increasing CD36-Dependent Cholesteryl Ester Accumulation in Macrophages
James Dressman Jeanie Kincer Sergey V. Matveev Ling Guo Richard N. Greenberg Theresa Guerin David Meade Xiang-An Li Weifei Zhu Annette Uittenbogaard Melinda E. Wilson Eric J. Smart 		Journal of Clinical Investigation 2003
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL
CJ Binder, S Hörkkö, A Dewan, MK Chang, EP Kieu, CS Goodyear, PX Shaw, W Palinski, JL Witztum, GJ Silverman 		Nature Medicine 2003
AGI-1067: A Multifunctional Phenolic Antioxidant, Lipid Modulator, Anti-Inflammatory and Antiatherosclerotic Agent
CL Sundell, PK Somers, CQ Meng, LK Hoong, KL Suen, RR Hill, LK Landers, A Chapman, D Butteiger, M Jones, D Edwards, A Daugherty, MA Wasserman, RW Alexander, RM Medford, U Saxena 		The Journal of pharmacology and experimental therapeutics 2003
Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice
J Zhou, J Møller, M Ritskes-Hoitinga, ML Larsen, RC Austin, E Falk 		Atherosclerosis 2003
Effects of 3-deazaadenosine on homocysteine and atherosclerosis in apolipoprotein E-deficient mice
AC Langheinrich, RC Braun-Dullaeus, G Walker, I Jeide, R Schilling, K Tammoscheit, T Dreyer, L Fink, RM Bohle, W Haberbosch 		Atherosclerosis 2003
The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
P Davenport, PG Tipping 		The American Journal of Pathology 2003
Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice
MM Elloso, N Azrolan, SN Sehgal, PL Hsu, KL Phiel, CA Kopec, MD Basso, SJ Adelman 		American Journal of Transplantation 2003
The Antiatherogenic Effect of DiNAC: Experimental Findings Supporting Immunomodulation as a New Treatment for Atherosclerosis Related Diseases
K Pettersson, H Bergstrand 		Cardiovascular Drug Reviews 2003
CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice
WA Kuziel, TC Dawson, M Quinones, E Garavito, G Chenaux, SS Ahuja, RL Reddick, N Maeda 		Atherosclerosis 2003
Atherosclerosis as a paradigmatic disease of the elderly: role of the immune system
M Knoflach, B Mayrl, C Mayerl, R Sedivy, G Wick 		Immunology and Allergy Clinics of North America 2003

Advertisement